Diagnostic Performance of Various Tests and Criteria Employed in Allergic Bronchopulmonary Aspergillosis: A Latent Class Analysis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Agarwal, Ritesh ^a   Maskey, Dipesh ^a   Aggarwal, Ashutosh Nath ^a   Saikia, Biman ^a   Garg, Mandeep ^a   Gupta, Dheeraj ^a   Chakrabarti, Arunaloke ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; PRECIPITIN;

ADOLESCENT; ADULT; AGARWAL CRITERIA; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHIECTASIS; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; EOSINOPHIL COUNT; FEMALE; HIGH ATTENUATION MUCUS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; INTERMETHOD COMPARISON; LATENT CLASS ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATTERSON CRITERIA; PREVALENCE; SENSITIVITY AND SPECIFICITY; SENSITIZATION; SKIN TEST; STATISTICAL ANALYSIS; THORAX RADIOGRAPHY;

ADULT; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

ASPERGILLUS;

EID: 84876093410     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061105     Document Type: Article

References (50)

1. Agarwal R, (2009) Allergic bronchopulmonary aspergillosis. Chest 135: 805-826.
2. Tillie-Leblond I, Tonnel AB, (2005) Allergic bronchopulmonary aspergillosis. Allergy 60: 1004-1013.
3. Agarwal R, Chakrabarti A (2010) Clinical manifestations and natural history of allergic bronchopulmonary aspergillosis. In: Pasqualotto AC, editor. Aspergillosis: From Diagnosis to Prevention. New York: Springer. 707-724.
4. Agarwal R, Chakrabarti A (2010) Epidemiology of allergic bronchopulmonary aspergillosis. In: Pasqualotto AC, editor. Aspergillosis: From Diagnosis to Prevention. New York: Springer. 671-688.
5. Denning DW, Pleuvry A, Cole DC (2013) Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol In Press doi: 10.3109/13693786.13692012.13738312.
6. Agarwal R, Aggarwal AN, Gupta D, Jindal SK, (2009) Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 13: 936-944.
7. Hogan C, Denning DW, (2011) Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin Respir Crit Care Med 32: 682-692.
8. Agarwal R (2010) Controversies in allergic bronchopulmonary aspergillosis. Int J Respir Care 6: 53-54, 56-63.
9. Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, et al. (1977) Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 86: 405-414.
10. Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M, (1986) Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146: 916-918.
11. Agarwal R, Hazarika B, Gupta D, Aggarwal AN, Chakrabarti A, et al. (2010) Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Med Mycol 48: 988-994.
12. Hui SL, Walter SD, (1980) Estimating the error rates of diagnostic tests. Biometrics 36: 167-171.
13. Rindskopf D, Rindskopf W, (1986) The value of latent class analysis in medical diagnosis. Stat Med 5: 21-27.
14. Nascimento MC, de Souza VA, Sumita LM, Freire W, Munoz F, et al. (2007) Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis. J Clin Microbiol 45: 715-720.
15. Girardi E, Angeletti C, Puro V, Sorrentino R, Magnavita N, et al. (2009) Estimating diagnostic accuracy of tests for latent tuberculosis infection without a gold standard among healthcare workers. Euro Surveillance 14: pii = 19373.
16. Machado de Assis TS, Rabello A, Werneck GL, (2012) Latent class analysis of diagnostic tests for visceral leishmaniasis in Brazil. Trop Med Int Health In Press: doi:10.1111/j.1365-3156.2012.03064.x.
17. Global Initiative for Asthma (GINA)- Global strategy for asthma management and prevention (2004). Available: http://wwwginasthmaorg/documents/5/documents_variants/27 Accessed 2013 March 12.
18. Agarwal R, Noel V, Aggarwal AN, Gupta D, Chakrabarti A, (2011) Clinical significance of Aspergillus sensitisation in bronchial asthma. Mycoses 54: e531-538.
19. Longbottom JL, Pepys J, (1964) Pulmonary aspergillosis: Diagnostic and immunological significance of antigens and C-Substance in Aspergillus Fumigatus. J Pathol Bacteriol 88: 141-151.
20. Aggarwal AN, Gupta D, Jindal SK, (2002) Development of a simple computer program for spirometry interpretation. J Assoc Physicians India 50: 567-570.
21. Reiff DB, Wells AU, Carr DH, Cole PJ, Hansell DM, (1995) CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. AJR Am J Roentgenol 165: 261-267.
22. Sim J, Wright CC, (2005) The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 85: 257-268.
23. Pouillot R, Gerbier G, Gardner IA, (2002) "TAGS". a program for the evaluation of test accuracy in the absence of a gold standard. Prev Vet Med 53: 67-81.
24. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (2012). Available: http://www.ginasthma.org/local/uploads/files/GINA_Report_2012Feb13.pdf.Accessed 2013 March 12.
25. Greenberger PA, Patterson R, (1988) Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 81: 646-650.
26. Eaton T, Garrett J, Milne D, Frankel A, Wells AU, (2000) Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest 118: 66-72.
27. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK, (2006) Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 130: 442-448.
28. Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, et al. (2007) Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 132: 1183-1190.
29. Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Saikia B, et al. (2010) Clinical significance of decline in serum IgE Levels in allergic bronchopulmonary aspergillosis. Respir Med 104: 204-210.
30. Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, et al. (2010) An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One 5: e15346.
31. Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A, (2010) Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses 53: 138-143.
32. Agarwal R, Aggarwal AN, Gupta D, (2006) High-attenuation mucus in allergic bronchopulmonary aspergillosis: another cause of diffuse high-attenuation pulmonary abnormality. AJR Am J Roentgenol 186: 904.
33. Agarwal R, (2010) High attenuation mucoid impaction in allergic bronchopulmonary aspergillosis. World J Radiol 2: 41-43.
34. Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D, (2011) Pictorial essay: Allergic bronchopulmonary aspergillosis. Indian J Radiol Imaging 21: 242-252.
35. Gleich GJ, Averbeck AK, Swedlund HA, (1971) Measurement of IgE in normal and allergic serum by radioimmunoassay. J Lab Clin Med 77: 690-698.
36. Malo JL, Longbottom J, Mitchell J, Hawkins R, Pepys J, (1977) Studies in chronic allergic bronchopulmonary aspergillosis. 3. Immunological findings. Thorax 32: 269-274.
37. Angus RM, Davies ML, Cowan MD, McSharry C, Thomson NC, (1994) Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax 49: 586-589.
38. Grenier P, Mourey-Gerosa I, Benali K, Brauner MW, Leung AN, et al. (1996) Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability. European Radiology 6: 199-206.
39. Ward S, Heyneman L, Lee MJ, Leung AN, Hansell DM, et al. (1999) Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 173: 937-942.
40. Jensen SP, Lynch DA, Brown KK, Wenzel SE, Newell JD, (2002) High-resolution CT features of severe asthma and bronchiolitis obliterans. Clin Radiol 57: 1078-1085.
41. Fairs A, Agbetile J, Hargadon B, Bourne M, Monteiro WR, et al. (2010) IgE sensitisation to Aspergillus fumigatus is sssociated with reduced lung function in asthma. Am J Respir Crit Care Med 182: 1362-1368.
42. Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R, (2011) Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy 66: 679-685.
43. Harmanci E, Kebapci M, Metintas M, Ozkan R, (2002) High-resolution computed tomography findings are correlated with disease severity in asthma. Respiration 69: 420-426.
44. Hamburger RN, (2005) Allergic Bronchopulmonary Aspergillosis with Normal Serum IgE in a Child with Cystic Fibrosis. Pediatr Asthma, Allerg Immunol 18: 46-47.
45. Kumar R, Gaur SN, (2000) Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma. Asian Pac J Allergy Immunol 18: 181-185.
46. Ghosh T, Dey A, Biswas D, Chatterjee S, Haldar N, et al. (2010) Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis among asthma patients in eastern India. J Indian Med Assoc 108: 863-865.
47. Agarwal R, (2011) Severe asthma with fungal sensitization. Curr Allergy Asthma Rep 11: 403-413.
48. Sheps SB, Schechter MT, (1984) The assessment of diagnostic tests. A survey of current medical research. JAMA 252: 2418-2422.
49. Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M, (1986) A framework for clinical evaluation of diagnostic technologies. CMAJ 134: 587-594.
50. Boelaert M, el Safi S, Goetghebeur E, Gomes-Pereira S, Le Ray D, et al. (1999) Latent class analysis permits unbiased estimates of the validity of DAT for the diagnosis of visceral leishmaniasis. Trop Med Int Health 4: 395-401.